The Biden administration has promised to invest billions in antiviral medicine development; certain hospitals associated with Black patients' COVID-19 mortality rates; increased rates of medicaid enrollment.
The Biden administration announced it will invest over $3 billion to accelerate the development of COVID-19 antiviral medicines, thanks to funds provided by the American Rescue Plan. The new Antiviral Program for Pandemics is a collaboration of the NIH, its National Institute of Allergy and Infectious Diseases, and the Biomedical Advanced Research and Development Authority. The plan also will create platforms for development of antivirals for other viruses that hold pandemic potential. With the goal of creating antiviral medicines taken at home early in the course of infection, the administration hopes to increase availability of breakthrough treatment options for the public in the future.
Findings of a cohort study involving over 44,200 Medicare beneficiaries suggested increased mortality among Black patients hospitalized with COVID-19 was associated with the hospitals at which these patients received care. Researchers looked at data from 1188 US hospitals and found odds of 30-day inpatient mortality or discharge to hospice were 11% higher for Black patients than for White patients. Results were adjusted for sociodemographic and clinical characteristics, and revealed the difference was largely eliminated when researchers adjusted for the hospital where care was received. Simulations showed that if Black patients were admitted to the same hospitals as White patients in the same distribution, their rate of mortality or discharge to hospice would decline.
Medicaid enrollment grew from 71.3 million in February 2020 to 80.5 million in January 2021, according to Kaiser Health News, with growth attributed to the pandemic-caused recession and a requirement to keep beneficiaries enrolled until the national emergency ends. Overall, more than 9 million people enrolled in the program over the past year. In comparison, around 56 million individuals were enrolled in 2013, prior to several states expanding medicaid under the Affordable Care Act. The program now covers nearly 1 in 4 Americans and has doubled in size since 2001. In total, Medicaid and Medicare cover 43% of the country’s population.
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Double Trouble: High-Deductible Plans Raise Maternity Care Costs Across 2 Calendar Years
June 27th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the June 2024 issue of The American Journal of Managed Care® about how annual high-deductible insurance plans increase maternity care costs when pregnancies cross 2 calendar years.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Support and Skepticism Emerge as Reactions to Robert F. Kennedy Jr’s HHS Nomination
November 15th 2024In the hours after President-elect Donald J. Trump tapped Robert F. Kennedy Jr to lead HHS, reactions came swiftly to the controversial pick who would have a large influence to shake up public health.
Read More